当前位置:首页 - 行情中心 - 众生药业(002317) - 财务分析 - 现金流量表

众生药业

(002317)

  

流通市值:179.67亿  总市值:200.50亿
流通股本:7.62亿   总股本:8.50亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金658,868,781.342,253,476,191.071,633,495,906.41,011,706,645
  收到的税费返还06,536,650.776,538,916.596,536,650.77
  收到其他与经营活动有关的现金13,805,340.07102,744,187.8139,525,156.5521,785,697.88
  经营活动现金流入小计672,674,121.412,362,757,029.651,679,559,979.541,040,028,993.65
  购买商品、接受劳务支付的现金165,209,060.62598,016,179.93414,949,308.71248,294,975.85
  支付给职工以及为职工支付的现金86,150,449.72252,126,312.04195,278,770.6134,950,389.6
  支付的各项税费45,991,558.32196,918,615.14145,102,393.6898,750,130.63
  支付其他与经营活动有关的现金233,788,358.381,010,491,339.86769,244,380.81518,369,234
  经营活动现金流出小计531,139,427.042,057,552,446.971,524,574,853.81,000,364,730.08
  经营活动产生的现金流量净额141,534,694.37305,204,582.68154,985,125.7439,664,263.57
二、投资活动产生的现金流量:
  收回投资收到的现金130,080,868.71,277,045,953.32757,950,191.91640,285,491.91
  取得投资收益收到的现金955,894.7122,085,754.520,609,266.4917,215,050.85
  处置固定资产、无形资产和其他长期资产收回的现金净额2,005,5908,203,175.97,969,459.694,822,079.69
  收到的其他与投资活动有关的现金67.1479.7579.7437.77
  投资活动现金流入小计133,042,420.551,307,334,963.47786,528,997.83662,322,660.22
  购建固定资产、无形资产和其他长期资产支付的现金48,410,357.59316,170,977.1193,178,273.01110,987,535.92
  投资支付的现金440,000,000945,000,000656,500,000431,000,000
  投资活动现金流出小计488,410,357.591,261,170,977.1849,678,273.01541,987,535.92
  投资活动产生的现金流量净额-355,367,937.0446,163,986.37-63,149,275.18120,335,124.3
三、筹资活动产生的现金流量:
  取得借款收到的现金18,627,714.18327,946,995.65209,304,342.88209,304,342.88
  收到其他与筹资活动有关的现金163,876.8270,259,745.5968,429,904.4947,721,225.71
  筹资活动现金流入小计18,791,591398,206,741.24277,734,247.37257,025,568.59
  偿还债务支付的现金49,597,150304,285,470100,000,000100,000,000
  分配股利、利润或偿付利息支付的现金56,666.67170,311,295.4170,311,295.4170,311,295.4
  支付其他与筹资活动有关的现金966,070.28659,139,246.34531,576,061.53522,960,666.45
  筹资活动现金流出小计50,619,886.951,133,736,011.74801,887,356.93793,271,961.85
  筹资活动产生的现金流量净额-31,828,295.95-735,529,270.5-524,153,109.56-536,246,393.26
四、汇率变动对现金及现金等价物的影响-20,914.64-30,491.28-15,840.3-5,718.22
五、现金及现金等价物净增加额-245,682,453.26-384,191,192.73-432,333,099.3-376,252,723.61
  加:期初现金及现金等价物余额977,893,369.271,362,084,5621,362,084,5621,362,084,562
  期末现金及现金等价物余额732,210,916.01977,893,369.27929,751,462.7985,831,838.39
补充资料:
  净利润-266,704,568.89-184,821,629.29
  资产减值准备-30,717,430.08-9,746,361.61
  固定资产和投资性房地产折旧-69,592,858.55-35,925,817.99
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-69,592,858.55-35,925,817.99
  无形资产摊销-52,808,122-23,092,317.93
  长期待摊费用摊销-1,032,881.22-928,188.82
  处置固定资产、无形资产和其他长期资产的损失--6,049,345.32--171,158.15
  固定资产报废损失-1,155,813.89-418,350.38
  公允价值变动损失-19,489,239.27-6,347,793.14
  财务费用-2,309,369.55-2,213,911.58
  投资损失--16,577,557.9--9,921,614.62
  递延所得税-12,439,193.82-86,491.64
  其中:递延所得税资产减少-9,120,186.13-4,100,240.93
    递延所得税负债增加-3,319,007.69--4,013,749.29
  存货的减少-71,243,420.42-76,963,014.14
  经营性应收项目的减少--214,096,024.24--261,630,555.09
  经营性应付项目的增加--32,851,977.96--71,817,313.94
  其他-44,856,259.72-41,443,122.44
  债务转为资本-0-0
  一年内到期的可转换公司债券-0-0
  融资租入固定资产-0-0
  现金的期末余额-977,893,369.27-985,831,838.39
  减:现金的期初余额-1,362,084,562-1,362,084,562
  加:现金等价物的期末余额-0-0
  减:现金等价物的期初余额-0-0
  现金及现金等价物的净增加额--384,191,192.73--376,252,723.61
公告日期2026-04-292026-04-292025-10-312025-08-29
审计意见(境内)标准无保留意见
TOP↑